[1]
A. Tariq, “SAFETY AND EFFICACY OF PITAVASTATIN IN DYSLIPDEMIC/HYPERLIPIDEMIC PATIENTS”, IJHR, vol. 3, no. 1, pp. 67–74, Jan. 2025, doi: 10.71000/4gb3ww80.